|
Volumn 63, Issue 2, 2008, Pages 207-214
|
Intramyocardial injection of autologous bone marrow cells as an adjunctive therapy to incomplete myocardial revascularization - Safety issues
|
Author keywords
Angina; Angiogenesis; Cardiac surgery; Cells; Ischemia
|
Indexed keywords
BIOLOGICAL MARKER;
ADOLESCENT;
ADULT;
AGED;
ANGINA PECTORIS;
ANGIOGENESIS;
ARTICLE;
AUTOTRANSPLANTATION;
BONE MARROW CELL;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
CYTOLOGY;
ECHOCARDIOGRAPHY;
EPIDEMIOLOGY;
FEMALE;
FLOW CYTOMETRY;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 1 CLINICAL TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGINA PECTORIS;
BIOLOGICAL MARKERS;
BONE MARROW CELLS;
BONE MARROW TRANSPLANTATION;
ECHOCARDIOGRAPHY;
EPIDEMIOLOGIC METHODS;
FEMALE;
FLOW CYTOMETRY;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
MYOCARDIAL ISCHEMIA;
MYOCARDIAL REVASCULARIZATION;
NEOVASCULARIZATION, PHYSIOLOGIC;
TRANSPLANTATION, AUTOLOGOUS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 43549109242
PISSN: 18075932
EISSN: None
Source Type: Journal
DOI: 10.1590/S1807-59322008000200009 Document Type: Article |
Times cited : (11)
|
References (32)
|